Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Unitedhealth Group Inc’s stock clocked out at $315.39, up 1.61% from its previous closing price of $310.38. In other words, the price has increased by $1.61 from its previous closing price. On the day, 14.08 million shares were traded. UNH stock price reached its highest trading level at $317.94 during the session, while it also had its lowest trading level at $308.2.
Ratios:
To gain a deeper understanding of UNH’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.78.
On July 30, 2025, Oppenheimer reiterated its Outperform rating and also upped its target price recommendation from $400 to $325. Robert W. Baird Downgraded its Outperform to Neutral on June 11, 2025, while the target price for the stock was maintained at $312.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 10 ’25 when Conway Patrick Hugh sold 589 shares for $305.00 per share. The transaction valued at 179,645 led to the insider holds 10,398 shares of the business.
Conway Patrick Hugh bought 589 shares of UNH for $179,645 on Jun 10 ’25. On May 16 ’25, another insider, REX JOHN F, who serves as the President & CFO of the company, bought 17,175 shares for $291.12 each. As a result, the insider paid 4,999,919 and bolstered with 203,796 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 285640523776 and an Enterprise Value of 342873407488. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.66, and their Forward P/E ratio for the next fiscal year is 17.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 3.01. Its current Enterprise Value per Revenue stands at 0.811 whereas that against EBITDA is 10.212.
Stock Price History:
The Beta on a monthly basis for UNH is 0.46, which has changed by -0.4691298 over the last 52 weeks, in comparison to a change of 0.18469036 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is 9.23%, while the 200-Day Moving Average is calculated to be -25.82%.
Shares Statistics:
It appears that UNH traded 15.93M shares on average per day over the past three months and 11586900 shares per day over the past ten days. A total of 905.00M shares are outstanding, with a floating share count of 903.33M. Insiders hold about 0.26% of the company’s shares, while institutions hold 86.76% stake in the company. Shares short for UNH as of 1755216000 were 16603605 with a Short Ratio of 1.04, compared to 1752537600 on 12707260. Therefore, it implies a Short% of Shares Outstanding of 16603605 and a Short% of Float of 1.8399999999999999.
Dividends & Splits
With its trailing 12-month dividend rate of 8.51, UNH has a forward annual dividend rate of 8.51. Against a Trailing Annual Dividend Yield of 0.027418004The stock’s 5-year Average Dividend Yield is 1.46. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
The dynamic stock of Unitedhealth Group Inc (UNH) is currently being evaluated by a team of 20.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $2.06, with high estimates of $2.86 and low estimates of $1.57.
Analysts are recommending an EPS of between $16.82 and $16.0 for the fiscal current year, implying an average EPS of $16.24. EPS for the following year is $18.08, with 26.0 analysts recommending between $23.46 and $16.48.
Revenue Estimates
In the current quarter, 18 analysts expect revenue to total $113.22B. It ranges from a high estimate of $114.65B to a low estimate of $110.16B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $100.82BFor the next quarter, 18 analysts are estimating revenue of $114.03B. There is a high estimate of $116.38B for the next quarter, whereas the lowest estimate is $110.6B.
A total of 22 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $451.16B, while the lowest revenue estimate was $441.94B, resulting in an average revenue estimate of $448.2B. In the same quarter a year ago, actual revenue was $400.28BBased on 22 analysts’ estimates, the company’s revenue will be $467.62B in the next fiscal year. The high estimate is $487.21B and the low estimate is $440.27B.
